000 | 01826 a2200565 4500 | ||
---|---|---|---|
005 | 20250518041549.0 | ||
264 | 0 | _c20200309 | |
008 | 202003s 0 0 eng d | ||
022 | _a1098-1004 | ||
024 | 7 |
_a10.1002/humu.23817 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFanis, Pavlos | |
245 | 0 | 0 |
_aA novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major. _h[electronic resource] |
260 |
_bHuman mutation _c10 2019 |
||
300 |
_a1768-1780 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 | _aErythrocyte Indices |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetal Hemoglobin _xgenetics |
650 | 0 | 4 | _aGenetic Association Studies |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKruppel-Like Transcription Factors _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aProtein Conformation |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aSymptom Assessment |
650 | 0 | 4 |
_abeta-Globins _xgenetics |
650 | 0 | 4 |
_abeta-Thalassemia _xblood |
700 | 1 | _aKousiappa, Ioanna | |
700 | 1 | _aPhylactides, Marios | |
700 | 1 | _aKyrri, Andreani | |
700 | 1 | _aHadjigavriel, Michael | |
700 | 1 | _aChristou, Soteroula | |
700 | 1 | _aSitarou, Maria | |
700 | 1 | _aKleanthous, Marina | |
773 | 0 |
_tHuman mutation _gvol. 40 _gno. 10 _gp. 1768-1780 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/humu.23817 _zAvailable from publisher's website |
999 |
_c29716966 _d29716966 |